Cutting Prison Hepatitis C Rates: Costly, But Worth It?

4 May 2016

An estimated 17,000 California prisoners have hepatitis C. At prisons like the California Men’s Colony, new treatments have dramatically improved chances of survival. George Lavender/Marketplace

Dr. Jagpreet Chhatwal, assistant professor of radiology at Harvard Medical School, has studied the economics of treating hepatitis C in prisons and said that while the drugs are expensive, liver transplants and treatment for patients with hepatitis C in its later stages are also costly.

Read full story here.

CONNECT WITH US

Our team is known for excellence and developing customized end-to-end solutions that meet our clients’ needs.

©2024 Value Analytics Labs. All rights reserved | Terms of Service | Privacy Policy | Design by 9piksel